The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology

Register Free at
http://www.appliedclinicaltrialsonline.com/alzheimers


Event Overview:
Clinical trials targeting Alzheimer’s disease (AD) are frequently long and require raters to administer and score many instruments. Some of these instruments have complex scoring conventions which must be memorized and understood, while others have specific administration guidelines regarding the acceptability of patient prompts and other spontaneous verbal communications with subjects. Raters must be experienced with the dementia population and with the individual instruments specified for use in the protocol.

In this webinar, the challenges of using clinical outcomes will be presented. Common scale mistakes, administration challenges, and rater errors will be presented. In addition to real-world examples from recent and on-going AD clinical trials, a series of in-study ratings surveillance techniques will be presented, all of which are designed to improve data quality in an Alzheimer’s disease clinical trial.

Join David S. Miller, MD, Therapeutic Area Leader for Alzheimer’s disease at Bracket, for a 1 hour webinar that explores these challenges and proven solutions.


During this presentation, you’ll learn:
  • Fundamental challenges associated with clinical endpoints in AD trials
  • The most common errors made with cognitive, functional, and global outcomes in AD trials
  • Which remediation techniques can improve outcomes with these endpoints
For questions, contact Sara Barschdorf at sbarschdorf@advanstar.com

Who Should Attend:
  • Medical Directors
  • Clinical Trial Managers
  • Clinical Research Associates (CRAs)

Presenters:
Dr. David Miller, MD, MA
Therapeutic Area Leader
Bracket

Moderator:
Sara Barschdorf
Multimedia Producer
Applied Clinical Trials